CPRX(Delisted)
Catalyst (CPRX) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Catalyst market cap is -- and enterprise value is --.
Share Statistics
Catalyst has 122.42M shares outstanding, with a free float of 111.65M.
Valuation Ratios
Catalyst's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Liquidity
Catalyst's current ratio is 7.1, quick ratio is 6.84, and cash ratio is 5.71, showing its short-term liquidity position.
Return on Capital
Catalyst's ROE is 24.50%, ROA is 21.52%, and ROIC is 21.31%, showing its return on capital profile.
Profitability
Catalyst gross margin is 85.96%, operating margin is 44.83%, and net margin is 37.08%.
Cost Structure
Catalyst spends 1.92% of revenue on R&D and 39.20% on SG&A.
Operating Efficiency
Catalyst's asset turnover is 0.58, inventory turnover is 3.06, and receivables turnover is 5.91, indicating its operating efficiency.
Income Statement
Catalyst's revenue is 596.96M, gross profit is 513.14M, net income is 221.32M, and EBITDA is 305.83M.
Balance Sheet
Catalyst's total debt is 0, net debt is 0, total equity is 1.01B, and cash is 755.86M.
Cash Flow Statement
Catalyst's operating cash flow is 208.21M, free cash flow is 208.13M, and CapEx is -85.00K.
Dividends & Yields
Catalyst dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Catalyst's latest analyst rating is Hold, with an analyst target price of --.
Company Info
A commercial-stage biopharmaceutical company that develops prescription drugs for neuromuscular and neurological diseases and disorders
Per Share Metrics
Catalyst's EPS is 1.8, book value per share is 8.29, and free cash flow per share is 1.7.
